The survey showed nearly 99% of subscribers were “satisfied” with SmartTRAK as a resource for obtaining strategic insight, up-to-date market data, competitive intelligence, as well as an in-depth understanding of macro trends impacting the overall healthcare arena.
BioMedGPS, LLC announced May 9, key findings from a recent user survey evaluating SmartTRAK Business Intelligence, the medical device industry’s first real-time, competitive intelligence portal used by major companies participating in the orthopedics, wound care, regenerative medicine and neuro therapies industries.
Overall, the survey showed nearly 99% of subscribers were “satisfied” with SmartTRAK as a resource for obtaining strategic insight, up-to-date market data, competitive intelligence, as well as an in-depth understanding of macro trends impacting the overall healthcare arena.
The survey, which included responses from SmartTRAK subscribers from 14 of the top 15 global advanced wound care companies and 8 of the top 10 global orthopedic manufacturers, assessed subscriber satisfaction, usage and perceived importance as it relates to SmartTRAK’s products and tools.
Key Findings include:
Comments included:
“A dynamic industry needs a dynamic way to compile and analyze market data from all available sources in real time,” said Sharon O’Reilly, President & CEO of BioMedGPS. “This is where SmartTRAK is able to help. We appreciate the positive results and subscriber feedback in this recent survey and strive to continuously improve and surpass expectations.”
For a 30-day free trial of SmartTRAK's Daily Updates, simply fill out our form on SmartTRAK.com!
Free SmartTRAK Market Updates for a Month!